[
    [
        {
            "time": "",
            "orginal_text": "药明康德三季度净利润同比下滑 近期频遭股东减持 盈利能力下降",
            "features": {
                "keywords": [
                    "药明康德",
                    "三季报",
                    "净利润",
                    "同比下滑",
                    "股东减持",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "药明康德三季度净利润同比下滑 近期频遭股东减持 盈利能力下降",
            "scores": {
                "News_content": "药明康德三季度净利润同比下滑 近期频遭股东减持 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "背负有千钧！近两月142家公司超亿元减持",
            "features": {
                "keywords": [
                    "减持",
                    "公司数量",
                    "金额规模"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "背负有千钧！近两月142家公司超亿元减持",
            "scores": {
                "News_content": "背负有千钧！近两月142家公司超亿元减持",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药股核心资产集体新高 四大资金狂扫货 这些股目标涨幅30%以上",
            "features": {
                "keywords": [
                    "医药股",
                    "核心资产",
                    "新高",
                    "资金流入",
                    "目标涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药股核心资产集体新高 四大资金狂扫货 这些股目标涨幅30%以上",
            "scores": {
                "News_content": "医药股核心资产集体新高 四大资金狂扫货 这些股目标涨幅30%以上",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德涨逾4%破顶 绩后曾获里昂升目标价",
            "features": {
                "keywords": [
                    "药明康德",
                    "股价上涨",
                    "目标价上调",
                    "业绩后"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德涨逾4%破顶 绩后曾获里昂升目标价",
            "scores": {
                "News_content": "药明康德涨逾4%破顶 绩后曾获里昂升目标价",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医疗保健：短期看医保谈判 荐11股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "医保谈判",
                    "推荐股票"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗保健：短期看医保谈判 荐11股",
            "scores": {
                "News_content": "医疗保健：短期看医保谈判 荐11股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "港股医药板块发力",
            "features": {
                "keywords": [
                    "港股",
                    "医药板块",
                    "发力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "港股医药板块发力",
            "scores": {
                "News_content": "港股医药板块发力",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "【医药】江琦、谢木青：医药板块2019Q3分析暨11月月报：三季报期总结：结构性高增长持续，建议继续重点布局高景气板块-1102",
            "features": {
                "keywords": [
                    "医药板块",
                    "2019Q3",
                    "三季报",
                    "高增长",
                    "高景气板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【医药】江琦、谢木青：医药板块2019Q3分析暨11月月报：三季报期总结：结构性高增长持续，建议继续重点布局高景气板块-1102",
            "scores": {
                "News_content": "【医药】江琦、谢木青：医药板块2019Q3分析暨11月月报：三季报期总结：结构性高增长持续，建议继续重点布局高景气板块-1102",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]